Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

26. COVID-19 INFORMATION

v3.21.2
26. COVID-19 INFORMATION
12 Months Ended
Dec. 31, 2020
Notes  
26. COVID-19 INFORMATION

26.COVID-19 INFORMATION 

Since December 31, 2019, the outbreak of the novel strain of coronavirus, specifically identified as “COVID-19”, has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and physical distancing, have caused material disruption to business globally resulting in an economic slowdown. Global equity markets have experienced significant volatility and weakness. The duration and impact of the COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity of these developments and the impact on the consolidated financial results and condition of the Company in future periods.